Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab plus FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children's Oncology Group Report

被引：0
|
作者：
Cairo, Mitchell S. [1 ]
Lynch, James [2 ]
Harrison, Lauren [1 ]
van de Ven, Carmella [3 ]
Gross, Thomas [4 ]
Shiramizu, Bruce [5 ]
Sanger, Warren [6 ]
Perkins, Sherrie L. [7 ]
Goldman, Stanton [8 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY 43210 USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Childrens Oncol Grp, Omaha, NE 96822 USA
[3] Columbia Univ, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH USA
[5] Univ Hawaii, Honolulu, HI USA
[6] Univ Nebraska Med Ctr, Dept Human Genet, Omaha, NE USA
[7] ARUP Labs, Hematopathol Off, Salt Lake City, UT USA
[8] Med City Childrens, Dallas, TX USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [41] Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma
    Toelle, I
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfi, Ng M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    KLINISCHE PADIATRIE, 2023, 235 (03): : 203 - 203
  • [42] Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin lymphoma (NHL)
    Reiter, A.
    Meinhardt, A.
    Burkhardt, B.
    Zimmermann, M.
    Borkhardt, A.
    Kontny, U.
    Mann, G.
    Schrappe, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : CP50 - CP50
  • [43] Impact of Rituximab on Immune Status Following Therapy in Children with B-Cell Non-Hodgkin Lymphoma/Mature Acute Leukemia: A Report from Intergroup INTER-B-NHL RITUX 2010 Trial
    Alexander, S.
    Auperin, A.
    Pillon, M.
    Burke, A.
    Barkauskas, D. A.
    Wheatley, K.
    Delgado, R. F.
    Uyttebroeck, A.
    Bollard, C. M.
    Zsiros, J.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Patte, C.
    Gross, T. G.
    Minard-Colin, V.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S35 - S35
  • [44] Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Harting, Rekha
    Venugopal, Pararneswaran
    Gregory, Stephanie A.
    O'Brien, Teresa
    Bogdanova, Elena
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (06): : 406 - 412
  • [45] Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial
    Alexander, Sarah
    Auperin, Anne
    Bomken, Simon
    Csoka, Monika
    Kazanowska, Bernarda
    Chiang, Alan K.
    Andres, Mara
    Uyttebroeck, Anne
    Burke, G. A. Amos
    Pillon, Marta
    Bollard, Catherine M.
    Mussolin, Lara
    Verdu-Amoros, Jaime
    Neven, Benedicte
    Barkauskas, Donald A.
    Wheatley, Keith
    Patte, Catherine
    Gross, Thomas G.
    Minard-Colin, Veronique
    LANCET HAEMATOLOGY, 2023, 10 (06): : e445 - e457
  • [46] Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab (R-InO) versus chemotherapy for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL).
    Dang, Nam H.
    Ogura, Michinori
    Castaigne, Sylvie
    Fayad, Luis
    Jerkeman, Mats
    Radford, John A.
    Pezzutto, Antonio
    Bondarenko, Igor
    Stewart, Douglas Allan
    Shnaidman, Michael
    Sullivan, Sharon
    Vandendries, Erik
    Tobinai, Kensei
    Ramchandren, Rod
    Hamlin, Paul A.
    Gine, Eva
    Ando, Kiyoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY
    Minard-Colin, V.
    Auperin, A.
    Burke, A.
    Alexander, S.
    Moreno, M.
    Buffardi, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Verschuur, A.
    Miles, R.
    Wotherspoon, A.
    Barkauskas, D.
    Wheatley, K.
    Vassal, G.
    Adamson, P.
    Gross, T.
    Patte, C.
    Pillon, M.
    LEUKEMIA RESEARCH, 2022, 121 : S43 - S43
  • [48] Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial
    Mori, Tetsuya
    Osumi, Tomoo
    Kada, Akiko
    Ohki, Kentaro
    Koga, Yuhki
    Fukano, Reiji
    Fujita, Naoto
    Mitsui, Tetsuo
    Mori, Takeshi
    Saito, Akiko M.
    Nakazawa, Atsuko
    Kobayashi, Ryoji
    Sekimizu, Masahiro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (04) : 585 - 593
  • [49] Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.
    Minard-Colin, Veronique
    Auperin, Anne
    Pillon, Marta
    Burke, Amos
    Anderson, James Robert
    Barkauskas, Donald A.
    Wheatley, Keith
    Delgado, Rafael
    Alexander, Sarah
    Uyttebroeck, Anne
    Bollard, Catherine
    Zsiros, Jozsef
    Csoka, Monika
    Goma, Gisele
    Tulard, Anne
    Patte, Catherine
    Gross, Thomas G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Rituximab in B-cell disorders other than non-Hodgkin's lymphoma
    Bosly, A
    Keating, MJ
    Stasi, R
    Bradstock, K
    ANTI-CANCER DRUGS, 2002, 13 : S25 - S33
12345